ViH Articles

PIH18 A COST EFFECTIVENESS ANALYSIS OF A GENERAL VACCINATION PROGRAMME WITH THE NEW 10- VALENT PNEUMOCOCCAL NON- TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN SWEDEN

May 1, 2009, 00:00
PSY29 VARIABILITY OF FEES IN THE FIELD OF HAEMOGRAMS IN THE AUSTRIAN CONTRACT PHYSICIANS SECTOR

May 1, 2009, 00:00
PCN40 A COST-EFFECTIVENESS ANALYSIS OF BENDAMUSTINE AT A TERTIARY CANCER CENTER

May 1, 2009, 00:00
PUK18 PATIENT PREFERENCE FOR TAMSULOSIN OCAS (ORAL CONTROLLED ABSORPTION SYSTEM) OVER TAMSULOSIN MODIFIED RELEASE CAPSULES

May 1, 2009, 00:00
PIN25 AN ECONOMIC EVALUATION OF POSACONAZOLE IN THE TREATMENT OF INVASIVE ASPERGILLOSIS WITH REFRACTORY DISEASE IN KOREA

May 1, 2009, 00:00
PCN53 COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINE FOR PREVENTION OF CERVICAL CANCER IN TAIWAN

May 1, 2009, 00:00
PMS9 TREATING ARTHRITIS OF THE KNEE- THE IMPACT ON PAIN IN PATIENTS EVERYDAY LIVES

May 1, 2009, 00:00
PND34 DISEASE BURDEN AND TREATMENT PATTERNS OF PARKINSONS DISEASE IN A LONG TERM CARE SETTING

May 1, 2009, 00:00
PHP69 PHARMACIST OPINION AND PERCEIVED CONFIDENCE IN KNOWLEDGE REGARDING THE IMPACT OF MEDICARE PART D PRESCRIPTION DRUG BENEFIT PROGRAM ON PATIENT CARE

May 1, 2009, 00:00
PMH37 DISCRETE EVENT SIMULATION COMPARING QUALITY OF LIFE AND COSTS BETWEEN OLANZAPINE AND QUETIAPINE XR TREATMENT FOR SCHIZOPHRENIA IN MEXICO

May 1, 2009, 00:00
PMH20 RETROSPECTIVE COHORT STUDY OF THE EFFECTS OF EARLY VERSUS LATE TREATMENT OF INSOMNIA IN PATIENTS INITIATING ANTI-DEPRESSANT MEDICATIONS

May 1, 2009, 00:00
PIH45 THE IMPACT OF MEDICARE PART D ON HEALTH CARE UTILIZATION AND HEALTH OUTCOMES FOR MEDICARE BENEFICIARIES WITHOUT PREVIOUS DRUG COVERAGE

May 1, 2009, 00:00
PCN110 A RETROSPECTIVE CLAIMS DATABASE COMPARISON OF SORAFENIB AND SUNITINIB DOSING PATTERNS IN PATIENTS WITH RENAL CELL CARCINOMA (RCC)

May 1, 2009, 00:00
PCN56 IMPACT OF BONE METASTASES (BM) ON HEALTH CARE COSTS BEFORE AND AFTER OCCURRENCE OF SKELETAL RELATED EVENTS (SRES) IN MEN WITH PROSTATE CANCER (PC)

May 1, 2009, 00:00
PCN89 FACTORS IMPACTING THE HEALTH RELATED QUALITY OF LIFE IN FEMALE BREAST CANCER PATIENTS-AN OBSERVATIONAL, CROSS-SECTIONAL STUDY

May 1, 2009, 00:00
PSY13 FREQUENCY AND BOTHERSOMENESS OF SIDE EFFECTS IN PAIN PATIENTS TAKING OXYCODONE IMMEDIATE RELEASE- IMPACT ON PRESCRIPTION AND OVER-THE-COUNTER MEDICATION USE

May 1, 2009, 00:00
PIH5 AN ANALYSIS OF SELECT INJURY-INCREASING ANALGESIC MEDICATIONS IN MEDICARE DUAL ELIGIBLE ENROLLEES

May 1, 2009, 00:00
PHP83 WHAT IS THE FUTURE IN THE IMPLEMENTATION OF HEALTH TECHNOLOGIES IN THE PUBLIC SECTOR IN SPAIN? A QUALITATIVE STUDY EXPLORING KEY DECISION-MAKERS PERSPECTIVES

May 1, 2009, 00:00
PCN2 THE FREQUENCY OF OCCURRENCE OF SECONDARY MALIGNANT TUMORS EVOLVING ON THE FIELD OF PRIMARY BREAST CANCER IN THE FEMALE POPULATION OF HUNGARY BETWEEN 2003 AND 2007

May 1, 2009, 00:00
PSY49 DETERMINANTS OF MEDICAL SERVICES UTILIZATION IN CHRONIC NONCANCER PAIN PATIENTS

May 1, 2009, 00:00
PIN18 THE ESTABLISHMENT OF A COST-EFFECTIVE ANTIBIOTIC TREATMENT OF INFECTIVE ENDOCARDITIS AND MRSA BACTEREMIA IN MEXICAN PUBLIC HEALTH CARE SYSTEM

May 1, 2009, 00:00
MD5 PREDICTORS OF ENROLLMENT IN MEDICARE PART D- ARE BENEFICIARIES RATIONAL?

May 1, 2009, 00:00
PIH49 HORMONE REPLACEMENT THERAPY- AN ANALYSIS FOCUSING ON DRUG CLAIMS BY FEMALE SENIORS 2000 TO 2007

May 1, 2009, 00:00
HM3 IMPACT OF A SPECIALTY CARE MANAGEMENT PROGRAM ON MEDICATION ADHERENCE AND HEALTH CARE UTILIZATION AMONG NON-ELDERLY ADULTS WITH MULTIPLE SCLEROSIS

May 1, 2009, 00:00
PM1 PERSONALIZED MEDICINE- FACTORS INFLUENCING REIMBURSEMENT

May 1, 2009, 00:00
PCN31 COST OF CARE FOR MEDICARE PATIENTS DIAGNOSED WITH METASTATIC BREAST CANCER WHO RECEIVED TRASTUZUMAB

May 1, 2009, 00:00
PIH7 COMPARISON OF LEVONORGESTREL INTRAUTERINE SYSTEM (LNG-IUS) TO TUBAL LIGATION FOR CONTRACEPTION- A COST-EFFECTIVENESS ANALYSIS

May 1, 2009, 00:00
PDB26 RACE AND GENDER DIFFERENCES IN ECONOMIC BURDEN OF DIABETES HOSPITALIZATIONS IN TENNESSEE

May 1, 2009, 00:00
CO4 COMPARISON OF INPATIENT COST ESTIMATION METHODS- USING DATA FROM A CYSTIC FIBROSIS TRIAL

May 1, 2009, 00:00
PIN33 COST EFFECTIVENESS OF SWITCHING TO SECOND LINE THERAPY WITH LOPINAVIR/RITONAVIR (LPV/R) IN KENYA

May 1, 2009, 00:00
PCV67 COST AND OUTCOMES AFTER FIRST ACUTE MYOCARDIAL INFARCTION- STUDY ON 12049 INDIVIDUALS USING ADMINISTRATIVE DATABASES

May 1, 2009, 00:00
PMC24 A PREDICTION MODEL TO IDENTIFY SUBJECTS WITH HORMONE REFRACTORY PROSTATE CANCER (HRPC) FROM A MANAGED CARE ADMINISTRATIVE CLAIMS DATABASE

May 1, 2009, 00:00
PMH51 PSYCHOMETRIC PROPERTIES OF THE LIFE PARTICIPATION SCALE FOR ADULTS ASSESSING DEFICITS IN ADAPTIVE FUNCTIONING

May 1, 2009, 00:00
PUK11 AN ECONOMIC EVALUATION OF FESOTERODINE IN THE TREATMENT OF OVERACTIVE BLADDER (OAB) IN KOREA

May 1, 2009, 00:00
PMC67 THE TRANSLATION AND LINGUISTIC VALIDATION OF THE SUBJECTIVE WELL-BEING UNDER NEUROLEPTICS - SHORT VERSION (SWN-S) QUESTIONNAIRE

May 1, 2009, 00:00
PMC4 A FRAMEWORK FOR DEVELOPING A FLEXIBLE CONTROL-BASED ASTHMA POLICY MODEL

May 1, 2009, 00:00
PCV87 IS MEASURING HEALTH STATUS BENEFICIAL IN HEART FAILURE PATIENTS?

May 1, 2009, 00:00
UT4 SOCIAL PREFERENCES FOR EQ-5D HEALTH STATES- IS IT TIME TO CALL 'TIMEOUT' ON TTO?

May 1, 2009, 00:00
PMC33 IMPACT OF IGNORING CORRELATION BETWEEN INPUT PARAMETERS ON VARIANCE OF COST-UTILITY RATIOS

May 1, 2009, 00:00
PDB43 PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH

May 1, 2009, 00:00
HT3 A FRAMEWORK FOR DERIVING A MINIMALLY ACCEPTABLE TARGET CLINICAL PROFILE AND A MAXIMUM VALUE-BASED PRICE FOR DRUGS IN DEVELOPMENT TO MEET HEALTH TECHNOLOGY ASSESSMENT REQUIREMENTS

May 1, 2009, 00:00
PND38 EMPIRICAL CLASSIFICATION OF EPILEPSY TYPES IN INSURANCE CLAIMS DATA

May 1, 2009, 00:00
PCN14 FFECTIVENESS ANALYSIS OF CHEMOTHERAPY PLUS CETUXIMAB COMPARED WITH CHEMOTHERAPY ALONE IN THE TREATMENT OF METASTATIC COLORECTAL CANCER IN TAIWAN

May 1, 2009, 00:00
PHP3 HEALTH CARE PATTERNS AND PATIENT SATISFACTION IN EUROPE- A COMPARISON OF SIX COUNTRIES

May 1, 2009, 00:00
PMH2 USE OF HYPNOTICS/ANXIOLYTICS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER- ASSOCIATIONS WITH CHRONIC PAIN, SLEEP DISORDERS, AND ANTIDEPRESSANT SELECTION

May 1, 2009, 00:00
PCASE2 THE HOSPITAL AS IMPORTANT SOURCE OF INFORMATION REGARDING CHARACTERISTICS OF HEALTH CARE USERS

May 1, 2009, 00:00
PCN67 THE COST OF WAITING- ECONOMIC BENEFIT OF REDUCING WAITING TIMES FOR EARLY BREAST CANCER RADIOTHERAPY

May 1, 2009, 00:00
PCV12 FONDAPARINUX IS ECONOMICALLY NON-INFERIOR TO ENOXAPARIN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM

May 1, 2009, 00:00
PMC66 USE OF THE MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (M.I.N.I.) - VERSION 6 - IN AN INTERNATIONAL STUDY

May 1, 2009, 00:00
PCV18 ADHERENCE TO STATIN TREATMENT AND ACHIEVING LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) GOALS IN AN EMPLOYEE POPULATION

May 1, 2009, 00:00
PHP39 THE EFFECT OF THE WITHDRAWAL OF VISIT FEE ON THE NUMBER OF PATIENT-VISITS TO OUTPATIENT CARE DEPARTMENTS IN HUNGARY

May 1, 2009, 00:00
CN4 LEVERAGING MULTIPLE DATA SOURCES TO EVALUATE COST AND SURVIVAL IN FOLFOX OR FOLFIRI TREATED STAGE IV COLORECTAL CANCER PATIENTS

May 1, 2009, 00:00
PMC70 VALUING HEALTH FROM SCRATCH- THE APPLICATION OF COMMONSENSE PRINCIPLES TO THE DESIGN OF HEALTH STATE VALUATION METHODS

May 1, 2009, 00:00
PMS58 FIBROMYALGIA- RUSSIAN RHEUMATOLOGISTS DISEASE MANAGEMENT

May 1, 2009, 00:00
PGI16 FACTORS INFLUENCING GASTROESOPHAGEAL REFLUX DISEASE OUTPATIENTS CHOICES TO ACCESS DIFFERENT TIERS OF MEDICAL FACILITIES- THE PRELIMINARY STUDY OF A DISCRETE CHOICE EXPERIMENT

May 1, 2009, 00:00
PUK2 RESTRICTED ACCESS TO DRUGS IS ASSOCIATED WITH LESS OPTIMAL MINERAL METABOLISM CONTROL IN HEMODIALYSIS PATIENTS

May 1, 2009, 00:00
PHC7 DEVELOPMENT AND VALIDATION OF SPECIFIC HEALTH RELATED QUALITY OF LIFE QUESTIONNAIRE FOR HALITOSIS- THE HALITOSIS QUALITY OF LIFE QUESTIONNAIRE (HQLQ)

May 1, 2009, 00:00
PM2 IMPACT OF PHARMACOGENETICS ON THE COSTS OF MANAGING ADVERSE EVENTS WITH WARFARIN- A PROSPECTIVE ANALYSIS

May 1, 2009, 00:00
PDB44 EFFECTS OF INSULIN THERAPY ON THE DIABETES SYMPTOM CHECKLIST-REVISED (DSC-R)- DATA FROM A LARGE INSULIN CLINICAL TRIAL

May 1, 2009, 00:00
PDB1 LITERATURE REVIEW OF THE IMPACT OF OBESITY ON CARDIOVASCULAR OUTCOMES IN THE GENERAL POPULATION AND IN PATIENTS WITH TYPE-2 DIABETES

May 1, 2009, 00:00
PDB12 RISK FACTORS FOR DEMENTIA IN ELDERLY PATIENTS WITH DIABETES MELLITUS

May 1, 2009, 00:00
PMC62 ASSESSING THE QUALITY OF CONJOINT ANALYSIS APPLICATIONS IN HEALTH- A PILOT EVALUATION OF THE ISPOR CHECKLIST FOR GOOD RESEARCH PRACTICE IN CONJOINT ANALYSIS

May 1, 2009, 00:00
PIN8 THE ECONOMIC IMPACT OF TRANSITIONING VALACYCLOVIR TO OVER THE COUNTER STATUS FOR THE TREATMENT OF GENITAL HERPES

May 1, 2009, 00:00
PMH5 PATIENT ASSESSED QUALITY OF LIFE VERSUS CLINICIAN ASSESSMENT- A POST-HOC ANALYSIS OF A TRIAL OF ARIPIPRAZOLE IN ADOLESCENT PATIENTS WITH SCHIZOPHRENIA

May 1, 2009, 00:00
PIN35 COST-EFFECTIVENESS OF MARAVIROC FOR HIV IN MEXICO

May 1, 2009, 00:00
PHP16 MARKET DISCONTINUATION OF PHARMACEUTICALS IN THE UNITED STATES- ANALYSIS OF DRUGS APPROVED BY THE FDA FROM 1939 TO 2008

May 1, 2009, 00:00
PMH81 THE IMPACT OF SUBTHERAPEUTIC INITIAL DOSING ON ADHERENCE TO ANTI-DEPRESSANTS IN THE TREATMENT OF DEPRESSION AND/OR ANXIETY

May 1, 2009, 00:00
PMC42 FINITE MIXTURE REGRESSIONS IN MODELING PRESCRIPTION DRUG UTILIZATION AND PRESCRIPTION DRUG EXPENDITURES OF PATIENTS WITH REUMATOID ARTHRITIS (RA)

May 1, 2009, 00:00
PMS33 BURDEN OF ILLNESS OF CONSERVATIVE MEDICAL MANAGEMENT OF OSTEOPOROTIC VERTEBRAL COMPRESSION FRACTURES IN JAPAN

May 1, 2009, 00:00
PDB65 ASSOCIATIONS BETWEEN PATIENT-REPORTED DIABETES KNOWLEDGE AND HEALTH OUTCOMES, SELF-CARE, AND PREFERENCES FOR POTENTIALLY-BENEFICIAL NEW TREATMENT OPTIONS

May 1, 2009, 00:00
PGI10 BURDEN OF SURGICALLY RESECTED GASTROINTESTINAL STROMAL TUMORS (GIST) IN THE US

May 1, 2009, 00:00
PMC21 DOES VARYING SELECTION BIAS CORRECTION TECHNIQUE MATTER IN ESTIMATION OF TREATMENT EFFECTS IN PRESENCE OF MULTIPLE ENDOGENOUS TREATMENTS?

May 1, 2009, 00:00
PND9 IS GENETIC TESTING IN COMBINATION WITH PREVENTIVE DONEPEZIL (ARICEPT) TREATMENT FOR PATIENTS WITH MILD COGNITIVE IMPAIRMENT COST- EFFECTIVE?

May 1, 2009, 00:00
QL3 ESTIMATION OF UTILITY VALUES FOR DIABETESXD-RELATED COMPLICATIONS ON QUALITY OF LIFE FOR PATIENTS WITH TYPE-2 DIABETES IN ONTARIO, CANADA

May 1, 2009, 00:00
PDB4 METFORMIN TREATMENT FOR IMPROVING OUTCOMES RELATED TO INFERTILITY IN POLYCYSTIC OVARY SYNDROME - A BAYESIAN ANALYSIS

May 1, 2009, 00:00
PCN1 TIME DELAY OF OCCURRENCE OF SECONDARY MALIGNANT TUMORS AFTER PRIMARY BREAST CANCER IN THE FEMALE POPULATION OF HUNGARY BETWEEN 2003 AND 2007

May 1, 2009, 00:00
PHP59 INCIDENCE AND OUTCOMES OF POTENTIAL DRUG-DRUG INTERACTIONS AMONG MEDICARE PART D PATIENTS

May 1, 2009, 00:00
PHP14 HAVE YOUR CAKE OR EAT IT- DO DECISIONS BASED ON COSTEFFECTIVENESS UNDERMINE INCENTIVES FOR RESEARCH AND DEVELOPMENT?

May 1, 2009, 00:00
PCN41 EVIDENCE SYNTHESIS FOR MODELING THE NATURAL HISTORY OF ANAL PENILE AND OROPAHRYNGEAL CANCERS

May 1, 2009, 00:00
FD3 CONCEPTUAL ISSUES IN THE DEVELOPMENT OF A MEASURE OF FORMULARY CULTURE

May 1, 2009, 00:00
PC4V19 EFFECT OF ACE INHIBITORS/ARBS AND STATINS ON THE INCIDENCE OF DEMENTIA, IN PATIENTS WITH CHRONIC HEART FAILURE

May 1, 2009, 00:00
PIH41 PATIENT SATISFACTION AND PERCIEVED CARE IN OBSTETRICIANS AND GYNECOLOGISTS COMPARED TO OTHER SPECIALTIES- ANALYSIS OF US SELF-REPORTED SURVEY DATA

May 1, 2009, 00:00
PCN105 GUIDELINES AND CANCER SCREENING IN THE UNITED STATES AND CANADIAN HEALTH SYSTEMS

May 1, 2009, 00:00
PMC56 THE EFFECT OF RECALL PERIOD ON CANCER PATIENTS RATINGS OF THE SEVERITY OF MULTIPLE SYMPTOMS

May 1, 2009, 00:00
PSY35 THE RELATIONSHIP BETWEEN QUALITY OF LIFE, DISABILITY AND PAIN IN PATIENTS WITH FAILED BACK SURGERY SYNDROME

May 1, 2009, 00:00
PND17 DIRECT MEDICAL COSTS AND THE LIKELIHOOD OF HEALTH SERVICE UTILIZATION BEFORE AND AFTER INITIATION OF INTERFERON b1A-IM TREATMENT AMONG PERSONS WITH MULTIPLE SCLEROSIS (MS)

May 1, 2009, 00:00
PMH6 A COMPARATIVE REVIEW OF SAFETY, EFFICACY AND ECONOMICS OF OFF-LABEL PRESCRIBING OF LEADING ATYPICAL ANTIPSYCHOTICS

May 1, 2009, 00:00
PCN70 MODELLING THE COST EFFECTIVENESS OF FIRST-LINE COMBINATION TREATMENT WITH BEVACIZUMAB PLUS IRINOTECAN AND INFUSIONAL FLUOROPYRIMIDINES VERSUS IRINOTECAN AND INFUSIONAL FLUOROPYRIMIDINES IN METASTATIC COLORECTAL CANCER PATIENTS IN SWED ...

May 1, 2009, 00:00
PUK12 CLINICAL AND ECONOMIC EVALUATION OF OVERACTIVE BLADDER PATIENTS (OAB) FAILLING TO CONSERVATIVE MANAGEMENT IN SPAIN- A FOUR HOSPITAL BASED ECONOMIC MODEL

May 1, 2009, 00:00
PIH53 IS MEDICARE PART D PLAN BENEFIT DESIGN ASSOCIATED WITH COST-RELATED NONADHERENCE TO PRESCRIPTION DRUGS? AN ANALYSIS USING THE MEDICARE CAHPS DATA

May 1, 2009, 00:00
PMH74 COMORBID ANXIETY AND HEALTH CARE UTILIZATION AMONG ADULTS WITH DEPRESSION

May 1, 2009, 00:00
PIN54 INCREASING CHC TREATMENT RATE IN US IS A COST-SAVING STRATEGY

May 1, 2009, 00:00
PMH17 HEALTH CARE COSTS ASSOCIATED WITH TREATMENT OF BIPOLAR DISORDER USING A MOOD STABILIZER PLUS ADJUNCTIVE ARIPIPRAZOLE, QUETIAPINE, RISPERIDONE, OLANZAPINE OR ZIPRASIDONE

May 1, 2009, 00:00
PSY27 THE LONG-TERM COST OF ORTHOPAEDIC SURGERY WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN HAEMOPHILIA INHIBITOR PATIENTS

May 1, 2009, 00:00
PUK21 IMPACTS OF THE PREVENTIVE TREATMENT OF PATIENTS SUFFERING FROM RECURRING CYSTITIS BY MEANS OF A STANDARD DRY CRANBERRY EXTRACT

May 1, 2009, 00:00
PHP49 THE CHANGING DYNAMICS IN HEALTH CARE FUNDING

May 1, 2009, 00:00
PHP13 COST-RELATED UNDERUSE OF MEDICINE DUE TO MEDICAID PHARMACY COST-CONTAINMENT POLICY ACTIONS

May 1, 2009, 00:00
PIN6 A DATA ANALYSIS OF INPATIENTS AFFECTED BY THE HUMAN PAPILLOMAVIRUS

May 1, 2009, 00:00
PMS3 COMPARISON OF 3 COMORBIDITY MEASURES AFFECTING PHYSICAL FUNCTION AND QUALITY OF LIFE FOR PATIENTS WITH ANKYLOSING SPONDYLITIS

May 1, 2009, 00:00
CASE5 HARMACOECONOMIC APPLICATIONS IN FORMULARY MANAGEMENT- A CASE STUDY OF ERLOTINIB AT A MAJOR CANCER CENTER

May 1, 2009, 00:00
PMH59 THE IMPACT OF THE FDA ANTIDEPRESSANT BLACK BOX WARNING ON THE CONTINUITY OF ANTIDEPRESSANT TREATMENT IN CHILDREN WITH DEPRESSION

May 1, 2009, 00:00
PMS18 ESTIMATION OF COSTS RELATED TO ADVERSE EVENTS IN NSAID TREATMENT OF OSTEOARTHRITIS - A COMPARISON BETWEEN CELECOXIB AND IBUPROFEN USING A VALIDATED MODEL

May 1, 2009, 00:00
PRS43 RACIAL DISPARITIES IN UTILIZATION OF ASTHMA CONTROLLER MEDICATIONS

May 1, 2009, 00:00
PHP38 THE POWER OF EPIDEMIOLOGICAL ESTIMATORS TO RATE INEQUALITIES IN HEALTH IN HIGH-INCOME OECD COUNTRIES, 1998-2002

May 1, 2009, 00:00
MS3 THE IMPACT OF COMPLIANCE WITH BIOLOGIC THERAPY ON CLINICAL OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS

May 1, 2009, 00:00
PHP26 THE IMPACT OF MEDICARE PART D ON MEDICARE-MEDICAID DUAL-ELIGIBLE BENEFICIARIES PRESCRIPTION UTILIZATION AND EXPENDITURES

May 1, 2009, 00:00
PCN92 HOW DOES TRUST IN PHYSICIANS AFFECT PARENTS TREATMENT DECISION MAKING FOR THEIR CHILDREN WITH LIFE-LIMITING CONDITIONS?

May 1, 2009, 00:00
PMC30 USING AN ENCOUNTER-BASED DATABASE TO VALIDATE A DISEASE PROGRESSION MODEL- LESSONS FOR MODELERS

May 1, 2009, 00:00
PCV63 INPATIENT BURDEN OF ILLNESS AND PREDICTORS OF CHARGES OR LENGTHS OF STAY AMONG ADULT HEART TRANSPLANTATION PATIENTS

May 1, 2009, 00:00
PCN62 FIRST YEAR COST EXPENDITURES ASSOCIATED WITH HEAD AND NECK CANCER DIAGNOSIS IN THE U.S. MANAGED CARE POPULATION

May 1, 2009, 00:00
PMC57 RELATIONSHIP BETWEEN QUALITY OF LIFE AND HEALTH-RELATED MEASURES INCLUDING SYMPTOMS, BIOCHEMICAL MARKERS AND TUMOR BURDEN

May 1, 2009, 00:00
PHP84 A COMPARISON OF REASONS FOR RECOMMENDATION AND REJECTION ACROSS FOUR HEALTH TECHNOLOGY APPRAISAL SYSTEMS CATEGORISED BY DISEASE

May 1, 2009, 00:00
PCN13 THE PREVALENCE AND COSTS OF ADVERSE METABOLIC EFFECTS OF ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC PATIENTS

May 1, 2009, 00:00
PRS41 APPROPRIATE USE OF INHALED CORTICOSTEROID AND LONG-ACTING -AGONIST COMBINATION THERAPY AMONG ASTHMA PATIENTS

May 1, 2009, 00:00
CASE4 DIABETES PHYSICIAN RECOGNITION IN A LARGE HEALTH PLAN

May 1, 2009, 00:00
PND30 DATA ANALYSIS OF PEDIATRIC INPATIENTS DIAGNOSED WITH BRAIN ABSCESS

May 1, 2009, 00:00
PMC88 AN EXPLORATORY ANALYSIS OF REASONS BEHIND PREMATURE TERMINATION OF RANDOMIZED CONTROLLED TRIALS

May 1, 2009, 00:00
PCV95 ELECTRONIC MEDICAL RECORD USE AND WARFARIN DRUG-DRUG INTERACTIONS DURING AMBULATORY VISITS IN THE UNITED STATES, 2003-2006

May 1, 2009, 00:00
PCN39 COST-EFFECTIVENESS ANALYSIS OF LUNG CANCER SCREENING WITH COMPUTED TOMOGRAPHY

May 1, 2009, 00:00
PND42 BRAZILIAN NATIONAL GUIDELINE FOR MULTIPLE SCLEROSIS (MS)- AN EXPLORATORY STUDY ABOUT THE IMPACT OF THE PATIENTS ADHERENCE IN THE TREATMENT COSTS

May 1, 2009, 00:00
PMH84 AN ASSESSMENT OF THE IMPACT OF AN EDUCATIONAL PHARMACY MANAGEMENT INTERVENTION ON PRESCRIBERS TO MEDICAID BENEFICIARIES

May 1, 2009, 00:00
PCV109 THERAPY INTERRUPTIONS IN PATIENTS SWITCHED FROM BRANDED TO OTHER GENERIC STATINS

May 1, 2009, 00:00
PMH72 IMPACT OF PHARMACY BENEFIT DESIGN ON ANTI-PSYCHOTIC MEDICATION ADHERENCE AND DISCONTINUATION

May 1, 2009, 00:00
PCV77 EVALUATION OF AN EDUCATIONAL ANTIHYPERTENSIVE MEDICATION ADHERENCE TOOL- IMPACT ON ANTIHYPERTENSIVE ADHERENCE AND BLOOD PRESSURE CONTROL

May 1, 2009, 00:00
PIN45 EMPLOYEES WILLINGNESS TO PAY FOR INFLUENZA VACCINATION OF HOUSEHOLD MEMBERS-RESULTS FROM THE CHILD AND HOUSEHOLD INFLUENZA-ILLNESS AND EMPLOYEE FUNCTION (CHIEF) STUDY

May 1, 2009, 00:00
PRS35 PREVALENCE OF ASTHMA, DIABETES MELLITUS AND ESSENTIAL HYPERTENSION AND ASSOCIATION OF HEALTH INSURANCE WITH BRAND STATUS OF DIAGNOSIS SPECIFIC PRESCRIPTION DRUGS

May 1, 2009, 00:00
PIH37 URINARY URGENCY INTENSITY RATING IN RELATION TO SYMPTOM FREQUENCY, BOTHER, AND TREATMENT SEEKING- RESULTS FROM EPILUTS IN THE US, UK, AND SWEDEN (SE)

May 1, 2009, 00:00
PCN90 A METHODOLOGICAL INVESTIGATION TO DEFINE A CLINICALLY RELEVANT CUT-OFF POINT IN THE ORDINAL SCALE OF THE EORTC QLQ-C30 QUESTIONNAIRE

May 1, 2009, 00:00
PMH26 THE COST BURDEN OF TREATMENT RESISTANCE IN PATIENTS WITH DEPRESSION

May 1, 2009, 00:00
PSY43 USE OF PRESCRIPTION PHARMACOTHERAPY IN PATIENTS WITH FIBROMYALGIA - EVIDENCE OF UNMET NEEDS?

May 1, 2009, 00:00
PIH4 PERSONALIZED MEDICINE- TRENDS IN CLINICAL STUDIES BASED ON NATIONAL REGISTRY DATA

May 1, 2009, 00:00
PCV91 DISPARITIES IN CORONARY ARTERY DISEASE CARE AMONG ENROLLEES WITH AARP MEDICARE SUPPLEMENT INSURANCE

May 1, 2009, 00:00
DU3 PATTERN OF UTILIZATION OF PEGFILGRASTIM IN PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA- A RETROSPECTIVE ANALYSIS OF ADMINISTRATIVE CLAIMS DATA

May 1, 2009, 00:00
PSS16 CHARACTERIZING FUNCTIONAL LIMITATIONS FOR ADULTS WITH DIABETIC RETINOPATHY

May 1, 2009, 00:00
PCN68 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUXTM) FOR THE FIRST LINE TREATMENT OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN CANADA

May 1, 2009, 00:00
PIH39 ASSOCIATION BETWEEN SEXUAL DRIVE CHANGE AND PREMENSTRUAL SYMPTOMS

May 1, 2009, 00:00
Prescribing Trends and Drug Budget Impact of the ARBs in the UK

Mar 1, 2009, 00:00
FDAMA 1997 Section 114- Another Look

Mar 1, 2009, 00:00
Who Does the Numbers? The Role of Third-Party Technology Assessment to Inform Health Systems' Decision-Making about the Funding of Health Technologies

Mar 1, 2009, 00:00
QALYs- Some Challenges

Mar 1, 2009, 00:00
Cost-Effectiveness of Primary versus Secondary Prophylaxis with Pegfilgrastim in Women with Early-Stage Breast Cancer Receiving Chemotherapy

Mar 1, 2009, 00:00
The Costs of Care in Atrial Fibrillation and the Effect of Treatment Modalities in Germany

Mar 1, 2009, 00:00
Cost Impact of Diagnostic Imaging for Lower Extremity Peripheral Vascular Occlusive Disease

Mar 1, 2009, 00:00
A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada

Mar 1, 2009, 00:00
Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes

Mar 1, 2009, 00:00
Mapping the English and Chinese Versions of the Functional Assessment of Cancer Therapy–General to the EQ-5D Utility Index

Mar 1, 2009, 00:00
The Health and Economic Consequences of Moderate Alcohol Consumption in Germany 2002

Mar 1, 2009, 00:00
What Ever Happened to FDAMA Section 114? A Look back after 10 Years

Mar 1, 2009, 00:00
Editorial- Moving the QALY Forward or Just Stuck in Traffic?

Mar 1, 2009, 00:00
A Longitudinal Evaluation of Health-Related Quality of Life of Patients with Parkinson's Disease

Mar 1, 2009, 00:00
A Different Approach to Health State Valuation

Mar 1, 2009, 00:00
Information on Center Characteristics as Costs' Determinants in Multicenter Clinical Trials- Is Modeling Center Effect Worth the Effort?

Mar 1, 2009, 00:00
Economic Evaluation of the Decisions of the Israeli Public Committee for Updating the National List of Health Services in 2006/2007

Mar 1, 2009, 00:00
Retaining, and Enhancing, the QALY

Mar 1, 2009, 00:00
Cost Analysis of Long-Term Treatment of Patients with Symptomatic Gastroesophageal Reflux Disease (GERD) with Esomeprazole On-Demand Treatment or Esomeprazole Continuous Treatment- An Open, Randomized, Multicenter Study in Switzerland

Mar 1, 2009, 00:00
Moving the QALY Forward- Rationale for Change

Mar 1, 2009, 00:00
What Outcomes Are Important to Patients with Long Term Conditions? A Discrete Choice Experiment

Mar 1, 2009, 00:00
Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model

Mar 1, 2009, 00:00
Predicting the Short Form-6D Preference-Based Index Using the Eight Mean Short Form-36 Health Dimension Scores- Estimating Preference-Based Health-Related Utilities When Patient Level Data Are not Available

Mar 1, 2009, 00:00
Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 Preference-Based SF-6D in Chronic Kidney Disease

Mar 1, 2009, 00:00
Editorial- On the Benefits of Modeling Using QALYs for Societal Resource Allocation- The Model Is the Message

Mar 1, 2009, 00:00
Excessive Hospitalizations and Its Associated Economic Burden among People with Diabetes in the United States

Mar 1, 2009, 00:00
Further Validation and Responsiveness Assessment of the Herpes Outbreak Impact Questionnaire and Herpes Symptom Checklist

Mar 1, 2009, 00:00
The Use of QALYs in Clinical and Patient Decision-Making- Issues and Prospects

Mar 1, 2009, 00:00
Cost-Effectiveness Evaluation of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections Accounting for Antibiotic Resistance

Mar 1, 2009, 00:00
Mapping Utility Scores from a Disease-Specific Quality-of-Life Measure in Bariatric Surgery Patients

Mar 1, 2009, 00:00
Modeling Length of Stay in Hospital and Other Right Skewed Data- Comparison of Phase-Type, Gamma and Log-Normal Distributions

Mar 1, 2009, 00:00
Cross-Cultural Validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial Questionnaire (SCOPA-PS) in Four Latin American Countries

Mar 1, 2009, 00:00
QALYs- The Basics

Mar 1, 2009, 00:00
Does Attribute Framing in Discrete Choice Experiments Influence Willingness to Pay? Results from a Discrete Choice Experiment in Screening for Colorectal Cancer

Mar 1, 2009, 00:00
Value of Information and Value of Implementation- Application of an Analytic Framework to Inform Resource Allocation Decisions in Metastatic Hormone-Refractory Prostate Cancer

Mar 1, 2009, 00:00
The Costs of Change- Direct Medical Costs of Solid Organ Transplantation in British Columbia, Canada, 1995–2003

Mar 1, 2009, 00:00
Toward a Consensus on the QALY

Mar 1, 2009, 00:00
Health Utilities in Patients with HIV/AIDS in Thailand

Mar 1, 2009, 00:00
Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument- The Potential to Estimate QALYs without Generic Preference Data

Jan 1, 2009, 00:00
Evaluation of an Internet-Based Disease Trajectory Decision Tool for Prostate Cancer Screening

Jan 1, 2009, 00:00
Validation of Gastrointestinal Quality of Life Index in Swedish for Assessing the Impact of Gallstones on Health-Related Quality of Life

Jan 1, 2009, 00:00
Satisfaction and Adherence in Patients with Iron Overload Receiving Iron Chelation Therapy as Assessed by a Newly Developed Patient Instrument

Jan 1, 2009, 00:00
Estimating a Preference-Based Single Index from the Overactive Bladder Questionnaire

Jan 1, 2009, 00:00
Breaking the Silence- Exploring the Potential Effects of Explicit Instructions on Incorporating Income and Leisure in TTO Exercises

Jan 1, 2009, 00:00
Utility Estimates for Decision–Analytic Modeling in Chronic Heart Failure—Health States Based on New York Heart Association Classes and Number of Rehospitalizations

Jan 1, 2009, 00:00
The Health Value and Cost of Care for Major Depression

Jan 1, 2009, 00:00
Development and Evaluation of the Adherence to Refills and Medications Scale (ARMS) among Low-Literacy Patients with Chronic Disease

Jan 1, 2009, 00:00
Budgetary Impact of Varenicline in Smoking Cessation in the United Kingdom

Jan 1, 2009, 00:00
Deterministic Sensitivity Analysis for First-Order Monte Carlo Simulations- A Technical Note

Jan 1, 2009, 00:00
The Effects of Laparoscopic Surgery and Nosocomial Infections on the Cost of Care- Evidence from Three Common Surgical Procedures

Jan 1, 2009, 00:00
Development of a New Questionnaire to Assess Patient Perceptions of Cancer-Related Fatigue- Item Generation and Item Reduction

Jan 1, 2009, 00:00
Potential for Cost-Savings in the Care of Hospitalized Low-Risk Community-Acquired Pneumonia Patients in China

Jan 1, 2009, 00:00
Prevention and Management of Hyperphosphatemia with Sevelamer in Canada- Health and Economic Consequences

Jan 1, 2009, 00:00
Using Conjoint Analysis to Estimate Healthy-Year Equivalents for Acute Conditions- An Application to Vasomotor Symptoms

Jan 1, 2009, 00:00
The Development of the Herpes Symptom Checklist and the Herpes Outbreak Impact Questionnaire

Jan 1, 2009, 00:00
ISPOR Code of Ethics

Jan 1, 2009, 00:00
An Empiric Estimate of the Value of Life- Updating the Renal Dialysis Cost-Effectiveness Standard

Jan 1, 2009, 00:00
Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment- A US Analysis Based on PROactive

Jan 1, 2009, 00:00
Cost-Effectiveness of Treatments Reducing Coronary Heart Disease Mortality in Ireland, 2000 to 2010

Jan 1, 2009, 00:00
Ultrasound-Guided Central Line Placement as Compared with Standard Landmark Technique- Some Unpleasant Arithmetic for the Economics of Medical Innovation

Jan 1, 2009, 00:00
Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate- Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer

Jan 1, 2009, 00:00
Gaining Efficiencies- Resources and Demand for Dialysis around the Globe

Jan 1, 2009, 00:00
Health State Valuation Methods and Reference Points- The Case of Tinnitus

Jan 1, 2009, 00:00
The Burden of Migraine in the United States- Current and Emerging Perspectives on Disease Management and Economic Analysis

Jan 1, 2009, 00:00
Reliability of the Discrete Choice Experiment at the Input and Output Level in Patients with Rheumatoid Arthritis

Jan 1, 2009, 00:00
The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer

Jan 1, 2009, 00:00
The Impact of Proton Pump Inhibitor Compliance on Health-Care Resource Utilization and Costs in Patients with Gastroesophageal Reflux Disease

Jan 1, 2009, 00:00
“Price Management” and Its Impact on Hospital Pharmaceutical Expenditure and the Availability of Medicines in New Zealand Hospitals

Dec 1, 2008, 00:00
Health State Utilities in Latent and Active Tuberculosis

Dec 1, 2008, 00:00
The Cost-Effectiveness of Atypicals in the UK

Dec 1, 2008, 00:00
Psychometric Equivalence of the OAB-q in Danish, German, Polish, Swedish, and Turkish

Dec 1, 2008, 00:00
Balancing Equity and Efficiency in Health Priorities in Ghana- The Use of Multicriteria Decision Analysis

Dec 1, 2008, 00:00
Reductions in Human Papillomavirus-Disease Resource Use and Costs with Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccination- The FUTURE Study Economic Evaluation

Dec 1, 2008, 00:00
Cost-Effectiveness of Preventing Hip Fractures by Hip Protectors in Elderly Institutionalized Residents in Germany

Dec 1, 2008, 00:00
A Predictive Model of Health State Utilities for HIV Patients in the Modern Era of Highly Active Antiretroviral Therapy

Dec 1, 2008, 00:00
Validity of the EuroQoL (EQ-5D) Instrument in a Greek General Population

Dec 1, 2008, 00:00
Sociodemographic and Clinical Correlates of Utility Scores in Alzheimer's Disease

Dec 1, 2008, 00:00
Estimating Quality Weights for EQ-5D Health States with the Time Trade-Off Method in South Korea

Dec 1, 2008, 00:00
Cost-Effectiveness of a Low-Calorie Diet and Orlistat for Obese Persons- Modeling Long-Term Health Gains through Prevention of Obesity-Related Chronic Diseases

Dec 1, 2008, 00:00
Factors Associated with Variation in Utility Scores among Patients with Prostate Cancer

Dec 1, 2008, 00:00
Citizen's Preferences Regarding Principles to Guide Health-Care Allocation Decisions in Thailand

Dec 1, 2008, 00:00
Health State Utility Scores for Cancer-Related Anemia through Societal and Patient Valuations

Dec 1, 2008, 00:00
Deriving an Algorithm to Convert the Eight Mean SF-36 Dimension Scores into a Mean EQ-5D Preference-Based Score from Published Studies (Where Patient Level Data Are Not Available)

Dec 1, 2008, 00:00
Statin Cost-Effectiveness Comparisons Using Real-World Effectiveness Data- Formulary Implications

Dec 1, 2008, 00:00
Drotrecogin Alfa's Impact on Intensive Care Workload in Real Life Practice- A Propensity Score Approach

Dec 1, 2008, 00:00
Hispanic Valuation of the EQ-5D Health States- A Social Value Set for Latin Americans

Dec 1, 2008, 00:00
Discrete-Event Simulation Applied to Analysis of Waiting Lists. Evaluation of a Prioritization System for Cataract Surgery

Dec 1, 2008, 00:00
Willingness to Accept versus Willingness to Pay in a Discrete Choice Experiment

Dec 1, 2008, 00:00
Expected Value of Perfect Information- An Empirical Example of Reducing Decision Uncertainty by Conducting Additional Research

Dec 1, 2008, 00:00
Estimation of Life Expectancy and the Expected Years of Life Lost in Patients with Major Cancers- Extrapolation of Survival Curves under High-Censored Rates

Dec 1, 2008, 00:00
Reviewer Acknowledgment

Dec 1, 2008, 00:00
Economic Valuation of Informal Care- Conjoint Analysis Applied in a Heterogeneous Population of Informal Caregivers

Dec 1, 2008, 00:00
PRS27 INTERPRETING SCORES ON THREE PATIENT-REPORTED OUTCOME MEASURES FOR ASTHMA

Nov 1, 2008, 00:00
PMS13 IMPACT OFVIOXX WITHDRAWAL ON VOLUME OF TOTAL HIP AND KNEE REPLACEMENTS

Nov 1, 2008, 00:00
PCN83 PERFORMANCE AND ADEQUACY OF PATIENT-PERSPECTIVE CRITERIA IN THE ASSESSMENT OF TEST-RETEST RELIABILITY- THE CASE OF THE PERFORM QUESTIONNAIRE

Nov 1, 2008, 00:00
PDB33 COST COMPARISON OF INSULIN GLARGINE AND INSULIN DETEMIR IN TYPE 2 DIABETES MELLITUS IN ARGENTINA- A TRIAL-BASED PROBABILISTIC MODEL

Nov 1, 2008, 00:00
PSS11 SENSITIVE SKINS IN FRANCE- AN EPIDEMIOLOGICAL APPROACH

Nov 1, 2008, 00:00
PSY32 COSTS OF A BLOODTRANSFUSION IN HEMATO-ONCOLOGIC PATIENTS IN A PORTUGUESE HOSPITAL

Nov 1, 2008, 00:00
PDB57 EFFECT OF INSULIN GLARGINE OR NPH INSULIN ON TREATMENT SATISFACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Nov 1, 2008, 00:00
PG137 A COMPARISON OF TREATMENT FAILURE RATES BASED ON STARTING ALGINATE THERAPY OBSERVED IN A LARGE REPRESENTATIVE LONGITUDINAL UK DATABASE

Nov 1, 2008, 00:00
PCN71 COST-EFFECTIVENESS OF ORALTOPOTECAN PLUS BEST SUPPORTIVE CARE VERSUS BEST SUPPORTIVE CARE ALONE IN PATIENTS WITH RELAPSED SMALL-CELL LUNG CANCER (SCLC) IN THE UK

Nov 1, 2008, 00:00
PCN85 PATIENT PREFERENCES IN THE THERAPY OF MULTIPLE MYELOMA

Nov 1, 2008, 00:00
PMS7 PREVALENCE OF FIBROMYALGIA- A LARGE-SCALE EUROPEAN SURVEY- EARLY RESULTS IN UNITED-KINGDOM

Nov 1, 2008, 00:00
PCN100 CONSUMPTION AND ACCESS TO INNOVATIVE CANCER DRUGS IN SLOVAKIA

Nov 1, 2008, 00:00
PIH8 COST-EFFECTIVENESS OF PLANNED CAESAREAN SECTION VERSUS PLANNEDVAGINAL DELIVERY IN BREECH-PRESENTATION PREGNANCIES AT TERM

Nov 1, 2008, 00:00
PRS26 THE EXACT-PRO INITIATIVE- DEVELOPMENT AND VALIDATION OF A SINGLE PATIENT-REPORTED OUTCOME MEASURE FOR EVALUATING EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Nov 1, 2008, 00:00
CN3 COST OF INITIAL PROSTATE CANCERTREATMENT FOLLOWING DIAGNOSIS PER PATIENT BY STAGE- ESTIMATES FROM THE UK, FRANCE, GERMANY, ITALY AND SPAIN

Nov 1, 2008, 00:00
PCN20 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT TRASTUZUMAB FOR TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER IN THE SAUDI ARABIAN SETTING

Nov 1, 2008, 00:00
PRS24 QUALITY OF LIFE RESULTS USING THE EUROQOL QUESTIONNAIRES AND DIRECT MEDICAL COSTS IN ASTHMATIC PATIENTS. CHAS STUDY

Nov 1, 2008, 00:00
PUK8 FESOTERODINE IS COST-EFFECTIVE FOR THE TREATMENT OF OVERACTIVE BLADDER- RESULTS OF AN ECONOMIC MODEL

Nov 1, 2008, 00:00
PHP9 DELAY OF DECISION-MAKING ON PHARMACEUTICAL REIMBURSEMENT IN NORMAL PROCEDURE IN HUNGARY

Nov 1, 2008, 00:00
PCV65 COSTS OF BLEEDS ASSOCIATED WITH TREATING ACUTE CORONARY SYNDROME PATIENTS IN GERMANY

Nov 1, 2008, 00:00
PCV10 SUPERIOR FORGIVENESS WITH ALISKIREN IN THE PRESENCE OF IMPERFECT COMPLIANCE

Nov 1, 2008, 00:00
PSS24 SYSTEMATIC REVIEW AND META-ANALYSIS OF RCTS REGARDING THE COMPARATIVE INCIDENCE OF HYPERAEMIA OF PROSTAGLANDIN TOPICAL GLAUCOMA MEDICATIONS

Nov 1, 2008, 00:00
PDB19 ESTIMATING THE COST EFFECTIVENESS IN THE UK OF VILDAGLIPTIN COMPARED TO PIOGLITAZONE AS ADD-ON THERAPY TO METFORMIN USING THE SHEFFIELD TYPE 2 DIABETES MODEL

Nov 1, 2008, 00:00
PIH24 ASSESSMENT OF CURRENT CLINICAL PRACTICE AMONG PHYSICIANS AND SEX THERAPISTS REGARDING ERECTILE DYSFUNCTION (ED) TREATMENT INITIATION WITH PHOSPHODIESTERASE-5 INHIBITORS (PDE5I)

Nov 1, 2008, 00:00
PRS23 IS THE EQ-5D RESPONSIVE TO RECOVERY FROM A MODERATE COPD EXACERBATION?

Nov 1, 2008, 00:00
QL2 TRANSLATION OF THE COLUMBIA SUICIDE SEVERITY RATING SCALE (C-SSRS) FOR USE IN 33 COUNTRIES

Nov 1, 2008, 00:00
PMS54 RELIEF OF PAIN AND SYMPTOMS IN KNEE CARTILAGE DEFECT IS ASSOCIATED WITH HIGHER SF-36 UTILITY SCORES- DATA FROM A PROSPECTIVE RANDOMIZED TRIAL OF CHONDROCELECT

Nov 1, 2008, 00:00
PSY39 IMPACT OF HIGHWAIST CIRCUMFERENCE ON PRODUCTIVITY IN US AND GERMAN OVERWEIGHT/OBESE SUBJECTS

Nov 1, 2008, 00:00
HT2 UPDATE OF RESULTS AND OUTCOMES OF NICE SINGLE TECHNOLOGY APPRAISALS-ECONOMIC CRITICISMS

Nov 1, 2008, 00:00
PMS44 PARAMEDICAL OR ALTERNATIVE TREATMENTS AND ASSOCIATED COSTS FOR THE MANAGEMENT OF FIBROMYALGIA IN FRANCE

Nov 1, 2008, 00:00
PSY1 A SYSTEMATIC REVIEW OF THE EFFICACY OF RECOMBINANT ACTIVATED FACTORVII (RFVIIA) AND ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) IN THE ON-DEMANDTREATMENT OF MINOR TO MODERATE BLEEDING EPISODES FOR HAEMOPHILIA PATIENTS WITH INHIBIT ...

Nov 1, 2008, 00:00
PG139 ALEGRIA, A REAL LIFE EVALUATION OF GERD (GASTROESOPHAGEAL REFLUX DISEASE) IMPACT OF SYMPTOM ASSESSMENT IN LUXEMBOUR

Nov 1, 2008, 00:00
PCV42 COST-EFFECTIVENESS OF POPULATION-BASED STRATEGIES DIRECTED AT ALBUMINURIA

Nov 1, 2008, 00:00
PDB61 CHART AUDIT OF THE DOSE AND EFFECTIVENESS OF LONG ACTING INSULIN ANALOGUES IN AUSTRALIAN CLINICAL PRACTICE

Nov 1, 2008, 00:00
PRS13 THE COST-EFFECTIVENESS OF VARENICLINE IN SMOKING CESSATION IN DENMARK

Nov 1, 2008, 00:00
PSS49 A DISEASE MODEL ILLUSTRATING THE IMPACT OF PSORIASIS ON PATIENTS LIVES

Nov 1, 2008, 00:00
PCN36 PHARMACOECONOMIC COMPARISON OF TWO PROTOCOLS FACVS. CMF IN THE TREATMENT OF EARLY BREAST CANCER

Nov 1, 2008, 00:00
PCV69 COST-EFFECTVENESS OF ENDOVASCULAR ANEURYSM REPAIR VERSUS OPEN SURGICAL REPAIR- NON-RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM IN AN ELECTIVE SETTING

Nov 1, 2008, 00:00
PMH7 PREVALENCE OF POTENTIAL MEDICATION INTERACTIONS WITH ANTIPSYCHOTICS VIA CYTOCHROME P450 IN PATIENTS WITH SCHIZOPHRENIA IN GERMANY

Nov 1, 2008, 00:00
PCV18 EFFECT OF ENVIRONMENTAL TEMPERATURE AND WORKDAYS ON HEART ATTACK FIGURES

Nov 1, 2008, 00:00
PND14 MEDICATION COSTS OF PATIENTS WITH CYSTIC FIBROSIS (CF) IN GERMANY

Nov 1, 2008, 00:00
PMC61 THE IMPLICIT VALUE OF STATISTICAL LIFE- ESTIMATES DERIVED FROM PUBLIC INTERVENTIONS IMPLEMENTED IN THE NETHERLANDS

Nov 1, 2008, 00:00
PIN14 USING A DECISION SIMULATION MODELTO EVALUATE THE COST-EFFECTIVENESS OF THE TREATMENT OF NUCLEOSIDE-NAVE HBE-ANTIGEN NEGATIVE CHB PATIENTS IN ITALY WITH ENTECAVIR AND TEN OF OVIR

Nov 1, 2008, 00:00
PG128 DEVELOPMENT AND PSYCHOMETRIC VALIDATION OF A NEW QUESTIONNAIRE MEASURING THE IMPACT OF CHILD GASTROENTERITIS ON PARENTS

Nov 1, 2008, 00:00
PHP42 EVALUATION OF THE AFTERNOON OUTPATIENT CLINICS OPERATION AT THE UNIVERSITY HOSPITAL IN LARISA

Nov 1, 2008, 00:00
PMS66 WILLINGNESS TO PAY VS. QUALITY ADJUSTEDWAGES AS ALTERNATIVE WAYS TO MEASURE THE BURDEN OF DISEASE IN SPAIN- AN APPLICATION TO BALLOON KYPHOPLASTY

Nov 1, 2008, 00:00
PMC48 UPDATE OF TRENDS IN THE INCLUSION OF PATIENT-REPORTED OUTCOME (PRO) DATA IN APPROVED DRUGS LABELING BY FDA AND EMEA

Nov 1, 2008, 00:00
PDB39 IS INSULIN GLARGINE A COST EFFECTIVE OPTION IN TREATMENT OF PATIENTS WITH TYPE DM1 WITH BASELINE HBA1C ABOVE 8 IN COMPARISON TO NPH AND PREMIX IN POLAND?

Nov 1, 2008, 00:00
PIN3 A SIMULATION-BASED APPROACH TO MODELING THE EFFECTS OF INTERVENTION STRATEGIES ON THE SPREAD OF MENINGOCOCCAL MENINGITIS

Nov 1, 2008, 00:00
PHP31 IS PATENT PROTECTION CREATING OPPORTUNITY FOR INNOVATION?-THE ALENDRONATE CASE IN BELGIUM

Nov 1, 2008, 00:00
PMC28 STATUS-QUO BIAS IN STATED-CHOICE STUDIES- IS IT REAL?

Nov 1, 2008, 00:00
PSY2 CONTRIBUTIONS OF THE FABRY OUTCOME SURVEY (FOS) TO ADVANCING THE MANAGEMENT OF FABRY DISEASE

Nov 1, 2008, 00:00
PSY25 SYSTEMATIC REVIEW OF THE COST OF ILLNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS

Nov 1, 2008, 00:00
PMC51 UTILITIES OF THE EQ-5D-TRANSFERABLE OR NOT? INFLUENCE OF THE NATIONAL VALUE SETS OF THE EQ-5D ON THE INCREMENTAL UTILITIES OF TWO HEALTH STATES

Nov 1, 2008, 00:00
PCV87 PERSISTENCE WITH AMIODARONE OR SOTALOL AND ITS IMPACT ON A TRIAL FIBRILLATION-RELATED HOSPITALIZATIONS AND CARDIOVERSIONS

Nov 1, 2008, 00:00
PSY12 COST-EFFECTIVENESS OF FOOD FOR SPECIAL MEDICAL PURPOSES RELATIVE TO STANDARD CARE IN PATIENTS UNDERGOING ABDOMINAL SURGERY

Nov 1, 2008, 00:00
PDB27 INSULIN GLARGINE AND NPH INSULIN-BASED REGIMENS REVEAL COMPARABLE TOTAL DIRECT TREATMENT COSTS IN TYPE 2 DIABETES PATIENTS.THE LONG-ACTING INSULIN GLARGINE VS. NPH INSULIN COST EVALUATION STUDY IN GERMANY (LIVE-DE)

Nov 1, 2008, 00:00
PSY38 IMPACT OF TENSION HEADACHE ON WORK PRODUCTIVITY LOSS AND ACTIVITY IMPAIRMENT

Nov 1, 2008, 00:00
PCN40 COST-EFFECTIVENESS OF TREATMENT WITH TRASTUZUMAB IN PATIENTS WITH EARLY BREAST CANCER FROM THE PORTUGUESE SOCIETAL PERSPECTIVE

Nov 1, 2008, 00:00
PSY62 A NATURAL EXPERIMENT TO ESTIMATE THE IMPACT OF A PREFERRED DRUG LIST POLICY FOR LONG ACTING NARCOTIC ANALGESICS ON COSTS AND UTILIZATION

Nov 1, 2008, 00:00
PHP30 COST DRIVERS IN THE PHARMACEUTICAL MARKET IN GERMANY IN 2007

Nov 1, 2008, 00:00
PMS63 PATIENT REPORTED OUTCOMES OF DIFFERENT SURGICAL PROCEDURES IN PATIENTS WITH CARTILAGE DEFECTS OF THE KNEE AFTER 1 TO 5YEARS

Nov 1, 2008, 00:00
PHP25 EVALUATING AN ONLINE FREEWARE CALCULATOR AND PLOTTER FOR ANALYZING COST EFFECTIVENESS DATA FOR FORMULARY DRUG CLASSES

Nov 1, 2008, 00:00
PIN47 VALIDATION OF THE SINONASAL OUTCOMETEST-16 (SNOT-16) IN PATIENTS WITH ACUTE BACTERIAL SINUSITIS

Nov 1, 2008, 00:00
PMS22 ADALIMUMAB, ETANERCEPT AND INFLIXIMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS-COST EFFECTIVENESS ANALYSIS IN POLISH SETTINGS

Nov 1, 2008, 00:00
PMH27 HEALTH SERVICE EXPENDITURES FOR PATIENTS WITH A DIAGNOSIS OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN GERMANY-AN AGE AND GENDER SPECIFIC ANALYSIS

Nov 1, 2008, 00:00
PSS41 USTEKINUMAB SIGNIFICANTLY IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS

Nov 1, 2008, 00:00
PCV122 MODELING THE EFFECT OF DIFFERENTIAL COMPLIANCE WITH ANTIHYPERTENSIVE DRUGS ON CLINICAL ENDPOINTS

Nov 1, 2008, 00:00
PG140 PROTON PUMP INHIBITORS MARKET IN PRIMARY CARE SETTING

Nov 1, 2008, 00:00
PCN45 ECONOMIC ANALYSIS OF THE CLINICAL OUTCOMES OF SURGICAL THERAPY (COST) TRIAL COMPARING LAPAROSCOPICALLY-ASSISTED COLECTOMY (LAC) WITH OPEN COLECTOMY (OC) FOR COLON CANCER

Nov 1, 2008, 00:00
PHP55 CHIRALTY AND HOSPITAL FORMULARY- A SECOND LIFE FOR A BLOCKBUSTER

Nov 1, 2008, 00:00
PMH47 QUANTIFYING UNMET NEEDS AMONG PATIENTS WITH DEPRESSION USING AN SSRI OR SNRI ACROSS FIVE EUROPEAN COUNTRIES USING PATIENT-REPORTED SURVEY DATA

Nov 1, 2008, 00:00
PSS28 VENOUS LEG ULCER. COSTS-OF-ILLNESS OF IN GERMANY. A NATIONAL CROSS-SECTIONAL STUDY

Nov 1, 2008, 00:00
PMC14 A FRAMEWORK FOR REAL-WORLD ECONOMIC EVALUATION BY INCORPORATING IMPLEMENTATION PARAMETERS

Nov 1, 2008, 00:00
IN1 COST EFFECTIVENESS ANALYSIS OF REYATAZ VERSUS KALETRA IN THE TREATMENT OF NAVE HIV PATIENTS IN ITALY

Nov 1, 2008, 00:00
PHP50 UNIVERSAL STEPS IN PERFORMING EARLY-STAGE MEDICAL TECHNOLOGY ASSESSMENT

Nov 1, 2008, 00:00
PMC58 THE POTENTIAL PENALTY FOR NOT SAMPLING FROM THE RISK SET IN NESTED CASE-CONTROL DESIGNS- EVIDENCE FROM SIMULATED DATA

Nov 1, 2008, 00:00
PND26 ARE THERE DIFFERENCES IN PATIENT SATISFACTION WITH INSOMNIA MEDICATIONS? PILOT RESULTS FROM A NOVEL REGISTRY

Nov 1, 2008, 00:00
PCV16 MONITORING POTENTIAL DRUG-DRUG INTERACTIONS-AN APPLICATION FOR PRESCRIPTION CLAIMS DATABASES

Nov 1, 2008, 00:00
MS1 PREVALENCE OF FIBROMYALGIA IN EUROPE- A TIP OF THE ICEBERG.RESULTS FROM A LARGE-SCALE SURVEY

Nov 1, 2008, 00:00
PSS9 SENSITIVE SCALP- AN EPIDEMIOLOGICAL APPROACH

Nov 1, 2008, 00:00
QL5 COMPARISON OF EQ-5D AND HUI3 IN PATIENTS WITH TINNITUS

Nov 1, 2008, 00:00
PDB47 THE SUITABILITY OF POLYCYSTIC OVARY SYNDROME-SPECIFIC QUESTIONNAIRES FOR MEASURING THE IMPACT OF PCOS ON QUALITY OF LIFE IN CLINICAL TRIALS

Nov 1, 2008, 00:00
PCN104 A BUDGET IMPACT MODEL FOR THE INTRODUCTION OF PANITUMUMAB, A NEWTHERAPY FOR THE MANAGEMENT OF METASTATIC COLORECTAL CANCER (MCRC) IN GREECE

Nov 1, 2008, 00:00
PCN46 COST-MINIMIZATION ANALYSIS OF CAPECITABINE VERSUS UFT/LEUCOVORIN FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC) IN BRAZIL

Nov 1, 2008, 00:00
QL11 FATIGUE REDUCTION AND PHYSICAL FUNCTION IMPROVEMENTS ASSOCIATED WITH INCREASED PRODUCTIVITY AT WORK AND AT HOME IN RHEUMATOID ARTHRITIS PATIENTS

Nov 1, 2008, 00:00
PCV31 ORAL ANTICOAGULATION AFTER MAJOR HIP OR KNEE REPLACEMENT SURGERIES

Nov 1, 2008, 00:00
PCN66 HOW COSTLY IS RADIOTHERAPY WITH PARTICLES? COST ANALYSIS OF EXTERNAL BEAM RADIOTHERAPY WITH CARBON IONS, PROTONS AND CONVENTIONAL PHOTONS

Nov 1, 2008, 00:00
PMS69 PATTERNS OF MORBIDITY AND DIRECT COSTS ASSOCIATED IN THE OSTEOPOROSIS SPANISH POPULATION SETTING

Nov 1, 2008, 00:00
CN1 PHARMACOECONOMIC APPLICATIONS IN FORMULARY MANAGEMENT- BUDGET IMPACT ANALYSIS OF PACLITAXEL PROTEIN-BOUND AT A MAJOR CANCER CENTER

Nov 1, 2008, 00:00
PCV17 COLD AND INACTIVITY- THE ULTIMATE FACTORS FOR HEART ATTACK

Nov 1, 2008, 00:00
PDB29 ESTIMATING THE DIRECT COST OF TYPE II DIABETES IN GREECE

Nov 1, 2008, 00:00
PIN18 ANALYSIS OF COST-EFFECTIVENESS OF ITRACONAZOLE IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN TURKISH SETTING

Nov 1, 2008, 00:00
QL7 INTERPRETING SCORES ON THREE COPD PATIENT-REPORTED OUTCOME MEASURES

Nov 1, 2008, 00:00
PCN16 ANALYSIS OF COSTS AND CONSEQUENCES IN CANCER PATIENTS RECEIVING CAPECITABINE

Nov 1, 2008, 00:00
PUK20 VALIDATION OF THE SPANISH VERSION OF THE PELVIC ORGAN PROLAPSE/URINARY INCONTINENCE SEXUAL QUESTIONNAIRE-SHORT FORM (PISQ-12)

Nov 1, 2008, 00:00
PG112 MODELING THE LONG-TERM COST-EFFECTIVENESS OF CRONIC HEP. B THERAPIES IN SPAIN

Nov 1, 2008, 00:00
QL6 ROLE OF DISEASE SPECIFIC INSTRUMENTS IN THE MEASUREMENT OF HEALTH-RELATED QUALITY OF LIFE IN CANCER CLINICAL TRIALS

Nov 1, 2008, 00:00
PMS29 COSTS AVOIDED BY DIAGNOSING FIBROMYALGIA IN SPANISH PATIENTS

Nov 1, 2008, 00:00
PCV11 EFFECTIVENESS OF DRUG-ELUTING STENTS VS. BARE METAL STENTS UNRESTRICTED USE IN PATIENTS WITH CORONARY HEART DISEASE IN SOCIAL SECURITY MEXICAN INSTITUTE

Nov 1, 2008, 00:00
PCV85 STROKE PATIENT RESOURCE USE AND CAREGIVER BURDEN OUTCOMES BY SEVERITY (RECOVERY) STUDY- METHODS AND RESULTS FROM THE ATHENS STROKE REGISTRY

Nov 1, 2008, 00:00
PSY42 E-DIARY COMPLIANCE IN ACUTE PAIN STUDIES

Nov 1, 2008, 00:00
PSS34 MODELLING THE LONG-TERM CLINICAL OUTCOMES OF MEDICAL MANAGEMENT OF PRIMARY OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION

Nov 1, 2008, 00:00
PHP40 INVESTIGATING THE PROMOTION OF HEALTH BEHAVIOR AND HEALTH-RELATED QUALITY OF LIFE BY APPLYING SELF-DETERMINATION THEORY- USING 'EXERCISE' AS AN EXAMPLE

Nov 1, 2008, 00:00
PCV70 COST-EFFECTIVENESS OF CLOPIDOGREL IN COMBINATION WITH ASPIRIN FOR ACUTE CORONARY SYNDROMES IN AUSTRALIA

Nov 1, 2008, 00:00
PUK18 VALIDATION OF THE URINARY SENSATION SCALE (USS)

Nov 1, 2008, 00:00
PSS14 DRY SKIN- AN EPIDEMIOLOGICAL APPROACH

Nov 1, 2008, 00:00
PCV92 DERIVING UTILITY VALUES FOR ACUTE CORONARY SYNDROMES FROM THE GENERAL POPULATION IN AUSTRALIA

Nov 1, 2008, 00:00
PG14 BUDGET IMPACT OF METHYLNALTREXONE SC ON A PUBLIC DRUG PROGRAM FORMULARY

Nov 1, 2008, 00:00
Disclosure Information

Nov 1, 2008, 00:00
PIN54 ADAPTATION CALIBRATION OF A UK MODEL OF MENINGOCOCCAL DISEASE TO THE US SETTING

Nov 1, 2008, 00:00
PCN47 ECONOMIC EVALUATION IN THE POSTOPERATIVE MANAGEMENT OF COLORECTAL CANCER PATIENTS IN GREECE

Nov 1, 2008, 00:00
PIN45 IMPACT OF PATIENT-HEALTH CARE PROVIDER COMMUNICATION- THE HIV/AIDS PATIENTS PERSPECTIVES

Nov 1, 2008, 00:00
PRS41 USE OF AN ELECTRONIC DIARY IN 55 COUNTIRES- WHAT ARE THE CHALLENGES?

Nov 1, 2008, 00:00
PHC11 THE BURDEN OF ADHESIOLYSIS DURING LAPAROSCOPIC GYNECOLOGICAL SURGERY

Nov 1, 2008, 00:00
PMC63 SYSTEMATIC REVIEW RELIABILITY- SENSITIVITY AND SPECIFICITY OF ONEVS.TWO REVIEWS

Nov 1, 2008, 00:00
PCV8 CLINICAL AND ECONOMIC IMPACT OF DRUG-ELUTING STENT AND BARE METAL STENT IN HONG KONG-A SINGLE CENTRE 'REALWORLD' EXPERIENCE

Nov 1, 2008, 00:00
PCV97 TREATMENTS FOR VARICOSE VEIN DISEASE- EXPECTATIONS AND EXPERIENCES OF PATIENTS

Nov 1, 2008, 00:00
PMH50 THE ROLE OF PRE-TREATMENT EXPECTANCY ON THE OUTCOME OF PRIMARY CARE TREATMENTS FOR DEPRESSION

Nov 1, 2008, 00:00
PRS16 THE HOSPITALIZATION COST OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UNIVERSITY HOSPITAL OF ALEXANDROUPOLIS, GREECE

Nov 1, 2008, 00:00
PCASE3 USING IN-HOUSE STRATEGIES TO OVERCOME INCONSISTENCIES BETWEEN EXPENDITURES AND BUDGETING

Nov 1, 2008, 00:00
PSS7 A MIXED TREATMENT COMPARISON OF TOPICAL OCULAR HYPOTENSIVES FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION

Nov 1, 2008, 00:00
PIH23 MEDICATION COSTS IN ELDERLY PATIENTS

Nov 1, 2008, 00:00
PSY5 FACTORS ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY

Nov 1, 2008, 00:00
PCN19 COST EFFECTIVENESS OF CETUXIMAB IN FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER- A MODELLING APPROACH FOR THE UK

Nov 1, 2008, 00:00
PCV12 AN ANALYSIS OF THE ANTIHYPERTENSIVE EFFECTIVENESS OF ARBS VS. ACE INHIBITORS

Nov 1, 2008, 00:00
PCN12 BUDGETARY IMPACT OF XELOX IN COLORECTAL CANCER IN ITALY

Nov 1, 2008, 00:00
PCV59 INPATIENT RESOURCE USE ASSOCIATED WITHTHE TREATMENT OF SECONDARY A TRIAL FIBRILLATION

Nov 1, 2008, 00:00
PMC7 SELF-REPORT VERSUS CAREGIVER REPORT OF HEALTH CARE UTILIZATION- IMPACT ON COST AND COST-EFFECTIVENESS

Nov 1, 2008, 00:00
PCV120 GLYCOPROTEIN INHIBITOR USE IN ACUTE CORONARY SYNDROME PATIENTS IN 2007- RESULTS FROM THE ANTIPLATELET TREATMENT OBSERVATIONAL STUDY (APTOR)

Nov 1, 2008, 00:00
PHP33 INFLUENCE OF MORBIDITY ON THE USE OF RESOURCES IN PRIMARY CARE- RETROSPECTIVE APPLICATION OF ACG AT A SPANISH INTERREGIONAL LEVEL

Nov 1, 2008, 00:00
PCN44 COST MINIMIZATION ANALYSIS OF ADVANCED GASTRIC CANCERTREATMENT WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN POLISH SETTING

Nov 1, 2008, 00:00
PIN24 ECONOMIC AND CLINICAL IMPACT OF IMPLEMENTATION OF AN ACELLULAR PERTUSSIS VACCINE IN CANADA

Nov 1, 2008, 00:00
PSS38 RELATION BETWEEN SELF REPORTED GLAUCOMA SYMPTOMS AND COMPLIANCE

Nov 1, 2008, 00:00
HT1 A SYSTEMATIC FRAMEWORK FOR COMPARING METHODS, PROCEDURES, AND IMPACT ACROSS HTA AGENCIES

Nov 1, 2008, 00:00
PND21 SYMPTOM SEVERITY IN PARKINSONS DISEASE SEVERITY

Nov 1, 2008, 00:00
OR3 ADJUSTING ICERS FOR FUTURE UNRELATED MEDICAL COSTS- DEVELOPMENT AND APPLICATION OF A TOOLKIT

Nov 1, 2008, 00:00
PCN33 ECONOMIC EVALUATION OF FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER (MCRC) BASED ON IRINOTECAN (FOLFIRI) BEVACIZUMAB OR CETUXIMAB, ADJUSTED BY KRAS GENE (WILD-TYPE (WT) OR MUTANT (MT))

Nov 1, 2008, 00:00
PMC9 DISCOUNTING COSTS AND BENEFITS OF HEALTH CARE PROGRAMMES- PROBLEMS OF THE SOCIAL TIME PREFERENCE APPROACH

Nov 1, 2008, 00:00
PMC40 STABILITY OF TREATMENT SATISFACTION WITH MEDICINES QUESTIONNAIRE (SATMED-Q) STRUCTURE IN DIFFERENT PATHOLOGY SAMPLES

Nov 1, 2008, 00:00
OR2 INCORPORATING DIFFUSION OF NEW MEDICINES IN A BUDGET IMPACT ANALYSIS

Nov 1, 2008, 00:00
PRS22 ARE THE MEASUREMENT PROPERTIES OF THE ASTHMA QUALITY OF LIFE QUESTIONNAIRE (AQLQ) CONSISTENT ACROSS LANGUAGES?

Nov 1, 2008, 00:00
PCV22 TOLERABILITY OF ROSUVASTATIN 40 MG COMPARED TO 20 MG IN THE TREATMENT OF HYPERCHOLESTEROLAEMIA- EVIDENCE FROM RANDOMISED CONTROLLED TRIALS

Nov 1, 2008, 00:00
PMH17 TREATMENT OF OPIATE DEPENDENT PATIENTS INWALES WITH BUPRENORPHINE/NALOXONE-A COST-EFFECTIVENESS EVALUATION

Nov 1, 2008, 00:00
PIN35 HEALTH ECONOMIC ASSESSMENT OF A PRE-PANDEMIC INFLUENZA VACCINE FOR GERMANY

Nov 1, 2008, 00:00
PRS5 ESTABLISHING THE INCIDENCE AND PREVALENCE OF MULTIPLE A TOPIC CONDITIONS IN UK- COHORT STUDY USING THE GENERAL PRACTICE RESEARCH DATABASE

Nov 1, 2008, 00:00
PMC15 IN OR OUT? EMPIRICAL EVIDENCE ON INCOME LOSSES IN HEALTH STATE VALUATIONS AND IMPLICATIONS FOR ECONOMIC EVALUATIONS

Nov 1, 2008, 00:00
PCV44 COST-EFFECTIVENESS MODEL OF IMPLANTABLE CARDIAC MONITORS (ICM) FOR PATIENTS TREATED WITH RADIOFREQUENCY CATHETER ABLATION FOR A TRIAL FIBRILLATION (PAAF) IN SPAIN

Nov 1, 2008, 00:00
PCN43 MODELING THE COST-EFFECTIVENESS OF PROSTATE CANCERTREATMENT WITH PARTICLE THERAPY

Nov 1, 2008, 00:00
PMH3 RISPERIDONE LONG-ACTING INJECTION (RLAI) IN THE TREATMENT OF SCHIZOPHRENIA- 3 MONTH PRELIMINARY RESULTS FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY (E-STAR) IN RUSSIA

Nov 1, 2008, 00:00
PCN29 ECONOMIC EVALUATION OF SUNITINIB FIRST-LINE FOR METASTATIC RENAL CELL CARCINOMAVERSUS SORAFENIB, TEMSIROLIMUS AND BEVACIZUMAB INTERFERON-ALFA IN THE SWEDISH HEALTH SERVICE SETTING

Nov 1, 2008, 00:00
PCN68 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS STANDARD REGIMEN IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND

Nov 1, 2008, 00:00
PMH10 TOLERABILITY OF ONCE-DAILY EXTENDED RELEASE QUETIAPINE COMPARED TO QUETIAPINE IMMEDIATE RELEASE- A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS IN SCHIZOPHRENIA

Nov 1, 2008, 00:00
PRS42 SMOKING-CESSATION ACROSS BORDERS- TRANSFERABILITY OF COST-EFFECTIVENESS RESULTS

Nov 1, 2008, 00:00
PCV19 THE TIME OF SUNRISE AND HOURS WITH DAYLIGHT MAY HAVE AN EFFECT ON THE SEASONALITY AND DIURNAL VARIATION OF A HEART ATTACK

Nov 1, 2008, 00:00
PCV78 ANEURYSM OCCLUSION IN ELDERLY PATIENTS WITH ANEURYSMAL SUBARACHNOID HAEMORRHAGE- A COST-UTILITY ANALYSIS

Nov 1, 2008, 00:00
PMS42 COST-UTILITY EVALUATION OF THE TREATMENT OF PATIENTS WITH OSTEOARTHRITIS WITH IN SAPONIFICATES OF AVOCADO AND SOY (PIASCLEDINE )

Nov 1, 2008, 00:00
PCN42 A SENSITIVITY ANALYSIS ON THE COST UTILITY OF BEVACIZUMAB, CAPECITABINE, AND OXALIPLATIN COMPARED WITH FOLFOX FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER (CRC)- A UK PERSPECTIVE

Nov 1, 2008, 00:00
PCV115 ASSESSING THE POTENTIAL BENEFITS OF CHANGING REIMBURSEMENT CRITERIA FOR LIPID LOWERINGTHERAPY IN KOREA

Nov 1, 2008, 00:00
PSY44 UNDERSTANDING AND ASSESSING THE IMPACT OF PRESCRIPTION WEIGHT LOSS MEDICATION; CONCEPTUAL, GENDER AND CULTURAL ISSUES

Nov 1, 2008, 00:00
PIH22 PRICE-ELASTICITY OF DEMAND FOR INFERTILITY SERVICES IN GERMANY

Nov 1, 2008, 00:00
PMS18 COSTS OF TREATMENT OF RHEUMATOID ARTHRITIS WITH BIOLOGICAL DRUGS

Nov 1, 2008, 00:00
PCV3 COMPARISON OF GOAL ATTAINMENT RATES BETWEEN USERS OF SIMVASTATIN 40 MG AND OTHER STATINS

Nov 1, 2008, 00:00
PIN52 UTILIZATION ANALYSIS AND IMPACT OF ANTIBACTERIAL AGENTS IN TWO LEADING UNIVERSITY HOSPITALS IN NEIGHBORING COUNTRIES WITH DIFFERENT GDP AND HEALTH CARE SYSTEM

Nov 1, 2008, 00:00
MO1 ADVANTAGES AND DISADVANTAGES OF MARKOV MODELS VERSUS DISCRETE EVENT MODELS FOR SIMULATING PATIENT FLOWS

Nov 1, 2008, 00:00
PCV68 IMPACT OF DRUG ELUTING STENTS ON CLINICAL AND ECONOMIC OUTCOMES IN AN UNSELECTED INTERVENTIONAL PRACTICE

Nov 1, 2008, 00:00
PSS25 COST-EFFECTIVENESS OF ETANERCEPT AND EFALIZUMAB IN THE MANAGEMENT OF MODERATE AND SEVERE PLAQUE PSORIASIS

Nov 1, 2008, 00:00
PIN5 IMPACT OF MASS VACCINATION WITH MMRV VERSUS MMR IN FRANCE ON THE EPIDEMIOLOGY OF VARICELLA AND HERPES ZOSTER, USING A DYNAMIC TRANSMISSION MODEL

Nov 1, 2008, 00:00
PMC30 THE IMPACT OF INITIAL DISEASE SEVERITY- AN APPLICATION TO EXISTING HEALTH ECONOMICS MODELS

Nov 1, 2008, 00:00
DB3 HEALTH CARE RESOURCE UTILIZATION AND COSTS IN INSULIN-DEPENDENT PATIENTS WITH TYPE 2 DIABETES UNDER REALWORLD CONDITIONS IN GERMANY- LIVE-SPP STUDY

Nov 1, 2008, 00:00
PMS68 ANTI-TUMOUR NECROSIS FACTOR- INHIBITOR DOSE CHANGES IN RHEUMATOID ARTHRITIS PATIENTS IN A PROSPECTIVE PATIENT REGISTRY SETTING

Nov 1, 2008, 00:00
PCV114 SEARCHING THE OPTIMAL TREATMENT MIX STRATEGY WITH A TREATMENT MIX CHART APPROACH-THE CASE OF CHOLESTEROL LOWERING IN SWEDEN

Nov 1, 2008, 00:00